News and Trends 28 May 2019 Viral Vaccines Could Be Weapons Against Alzheimer’s Disease …simplex virus type 1, and HIV have no vaccines available, and other vaccines give very weak protection, such as the influenza vaccines,” Ezzat told me. “We think that not taking… May 28, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 18 Oct 2017 Eli Lilly Offers German Biotech up to €1.5Bn to Develop mRNA Cancer Vaccines …and formulation, as well as the manufacturing of the vaccines for clinical studies. The biotech will also have an option to co-promote the mRNA vaccines in Germany. The vaccines will… October 18, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jun 2021 Patent Waiver on Covid-19 Vaccines Splits Opinions in Biotech Industry …at Belgian mRNA startup Ziphius Vaccines, only vaccine patents related to Covid-19 would be potentially affected. Ziphius is developing self-amplifying mRNA vaccines that can make a patient’s cells produce molecules… June 15, 2021 - 5 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
In Depth 5 Sep 2025 Closing treatment gaps in yellow fever: are germ-free egg-based vaccines the answer? …are being sought after to curb infection rates, a major one being germ-free egg-based vaccines. Table of contents Yellow fever cases on the rise: how can vaccines control spread? Around… September 5, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 25 Nov 2021 Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines …Covid-19 vaccines. Since March 2021, there have been four approved vaccines in the EU, and a number of these approvals have since been expanded for use as booster shots. More… November 25, 2021 - 6 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
Interview 12 Jun 2019 How Vaccines Could One Day Beat HIV …in this way. All other vaccines that have been tried are theoretical, in silico.” Aside from vaccines, there are many different approaches in development to reduce our dependence on antiretroviral… June 12, 2019 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022 Ziphius and UZ Ghent collaborating on manufacture of saRNA-based vaccines Ziphius Vaccines, a biopharmaceutical company developing vaccines and therapeutics based on self-amplifying RNA (saRNA), and UZ Ghent have entered a public-private collaboration for the scale up and manufacturing of prophylactic… October 7, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jun 2022 Eurocine Vaccines expands portfolio to develop HSV-2 vaccine Swedish company Vaccines AB (Eurocine Vaccines) has entered into a research and collaboration agreement with Redbiotec AG. The agreement gives Eurocine Vaccines the exclusive global rights to develop, manufacture and… June 15, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 17 Dec 2024 Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic Cancer vaccines are a kind of immunotherapy that are meant to recognize cancer cells in the body and destroy them. But what if they could prevent the spread of cancer… December 17, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jun 2022 Ziphius Vaccines and University of Antwerp to work on RNA-based delivery methods Belgian biopharma firm Ziphius Vaccines is set to collaborate with the University of Antwerp to research and develop a lipid library for optimized delivery systems of self-amplifying RNA-based drugs (saRNA)… June 9, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 3 Jul 2017 These Norwegian Biotech Execs are Bringing Back Cancer Vaccines & Oncolytic Viruses …ones that have failed and our approach is the RAS target. When you look at those who have failed with vaccines and particularly also in pancreatic cancer vaccines, they have… July 3, 2017 - 8 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Podcast 17 Nov 2023 How can life-saving vaccines be more affordable? …can be part of that discussion.” What are the issues about supply and affordability related to vaccines? Cordiner explained that, for vaccines, there has traditionally been a premium for recombinant… November 17, 2023 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email